Skip to main content

Glyxambi Dosage

Dosage form: tablet, film coated
Drug class: Antidiabetic combinations

Medically reviewed by Last updated on Nov 2, 2023.

Testing Prior to Initiation of GLYXAMBI

Recommended Dosage and Administration

The recommended dosage of GLYXAMBI is 10 mg empagliflozin/5 mg linagliptin once daily in the morning, taken with or without food. GLYXAMBI may be increased to 25 mg empagliflozin/5 mg linagliptin once daily for additional glycemic control.

Dosage Recommendations in Patients with Renal Impairment

GLYXAMBI is not recommended for use in patients with an eGFR less than 30 mL/min/1.73 m2 and contraindicated in patients on dialysis [see Indications and Usage (1), Contraindications (4), Warnings and Precautions (5.3), and Use in Specific Populations (8.6)].

Recommendations Regarding Missed Dose

  • If a dose is missed, instruct patients to take the dose as soon as possible.
  • Do not double up the next dose.

Temporary Interruption for Surgery

Withhold GLYXAMBI for at least 3 days, if possible, prior to major surgery or procedures associated with prolonged fasting. Resume GLYXAMBI when the patient is clinically stable and has resumed oral intake [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.2)].

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.